GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NUTEX Investments PLC (BUD:NUTEX) » Definitions » EV-to-EBIT

NUTEX Investments (BUD:NUTEX) EV-to-EBIT : -11.30 (As of Apr. 28, 2024)


View and export this data going back to 1996. Start your Free Trial

What is NUTEX Investments EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, NUTEX Investments's Enterprise Value is Ft-2,010.54 Mil. NUTEX Investments's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was Ft177.92 Mil. Therefore, NUTEX Investments's EV-to-EBIT for today is -11.30.

The historical rank and industry rank for NUTEX Investments's EV-to-EBIT or its related term are showing as below:

BUD:NUTEX' s EV-to-EBIT Range Over the Past 10 Years
Min: -168.02   Med: -12.16   Max: 22.58
Current: -11.3

During the past 13 years, the highest EV-to-EBIT of NUTEX Investments was 22.58. The lowest was -168.02. And the median was -12.16.

BUD:NUTEX's EV-to-EBIT is ranked better than
99.85% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.12 vs BUD:NUTEX: -11.30

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. NUTEX Investments's Enterprise Value for the quarter that ended in Dec. 2023 was Ft-2,032.75 Mil. NUTEX Investments's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was Ft177.92 Mil. NUTEX Investments's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -8.75%.


NUTEX Investments EV-to-EBIT Historical Data

The historical data trend for NUTEX Investments's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NUTEX Investments EV-to-EBIT Chart

NUTEX Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -144.09 -18.87 -107.09 -15.33 -11.43

NUTEX Investments Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -107.09 - -15.33 - -11.43

Competitive Comparison of NUTEX Investments's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NUTEX Investments's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where NUTEX Investments's EV-to-EBIT falls into.



NUTEX Investments EV-to-EBIT Calculation

NUTEX Investments's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-2010.537/177.921
=-11.30

NUTEX Investments's current Enterprise Value is Ft-2,010.54 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was Ft177.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NUTEX Investments  (BUD:NUTEX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

NUTEX Investments's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=177.921/-2032.7498
=-8.75 %

NUTEX Investments's Enterprise Value for the quarter that ended in Dec. 2023 was Ft-2,032.75 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was Ft177.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NUTEX Investments EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of NUTEX Investments's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


NUTEX Investments (BUD:NUTEX) Business Description

Traded in Other Exchanges
N/A
Address
Telepes u. 53., Budapest, HUN, 1147
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.

NUTEX Investments (BUD:NUTEX) Headlines

No Headlines